Skip to main content

Table 3 Comparison of treatment modalities

From: Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome

 

Time to symptom relief

% Chance of partial symptom relief

Can be combined with other therapies?

Treatment-associated mortality

Radiation Therapy

3–30 days (Armstrong et al. 1987; Mose et al. 2006; Ostler et al. 1997; Davenport et al. 1978; Rodrigues et al. 1993)

56–96 (Armstrong et al. 1987; Rodrigues et al. 1993)

Yes

Low

Chemotherapy

1–2 weeks (Rowell and Gleeson 2001)

59–77 (Rowell and Gleeson 2001)

Yes

Low

Stent placement

0–72 h (Hennequin et al. 1995; Rosch et al. 1992)

80–95 % (Uberoi 2006)

Yes

3–4 % (Uberoi 2006)

  1. Properties of various treatment modalities used in superior vena cava syndrome